台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    89.0
  • 漲跌
    ▼0.2
  • 漲幅
    -0.22%
  • 成交量
    69
  • 產業
    上市 生技醫療類股▼0.93%
  • 350人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
旭富 (4119)籌碼相關-富邦-北高雄 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-北高雄 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/29189.0000.0089.2012460.41%
2024/04/2500.00188.5088.50-1245-0.41%
2024/04/1800.00088.7088.3002500.00%
2024/04/03188.3000.0087.8012580.39%
2024/03/20088.1000.0087.6002780.00%
2024/03/18286.7000.0086.9022840.70%
2024/03/13387.7000.0087.9032851.05%
2024/03/11389.4000.0089.1032751.09%
2024/03/0400.00690.7090.90-6274-2.18%
2024/02/02190.601491.0790.80-13290-4.48%
2024/01/18194.3000.0094.3013110.32%
2024/01/09197.5000.0097.3013170.32%
2023/12/19196.6000.0096.7013030.33%
2023/12/15294.4500.0094.8022930.68%
2023/11/22389.3000.0089.7032501.20%
2023/11/14486.9000.0086.7042431.64%
2023/11/13288.2000.0088.2022330.86%
2023/10/300.191.8000.0090.200.12020.05%
2023/10/2700.000.291.1091.00-0.2200-0.08%
2023/10/2600.00190.2090.00-1200-0.50%
2023/10/2400.00091.1391.7002060.00%
2023/10/200.189.6000.0089.000.12150.05%
2023/10/19190.9000.0090.4012140.47%
2023/10/18190.2000.0090.1012220.45%
2023/10/170.192.5000.0092.100.12210.05%
2023/09/26195.0000.0095.1012750.36%
2023/09/200.195.5000.0095.200.12770.04%
2023/09/1900.00196.9096.00-1283-0.35%
2023/09/15197.3000.0096.8012860.35%
2023/09/140.197.8000.0097.200.12870.04%
2023/09/0600.002100.50100.00-2296-0.68%
2023/09/04299.8000.0099.6022980.67%
2023/08/0100.001104.00103.00-1393-0.25%
2023/07/311.1103.1100.00103.001.13970.28%
2023/07/271.1104.1600.00105.001.14050.28%
2023/07/2600.001114.50115.00-1401-0.25%
2023/07/120.5106.0000.00104.000.54640.11%
2023/07/103.3109.1400.00108.503.34700.71%
2023/07/051117.5000.00117.0014640.22%
2023/06/161119.5000.00120.0015420.18%
2023/05/251115.0000.00115.0018020.12%
2023/05/151117.5000.00116.5018750.11%
2023/05/021128.500.2126.44125.500.88540.10%
2023/04/2700.000123.00122.5008570.00%
2023/04/262124.0000.00123.5028590.23%
2023/04/251127.0100.00127.0018440.12%
2023/04/210126.5000.00126.5008340.00%
2023/04/201126.5000.00126.0018180.12%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-16天前
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章